Mylan came under pressure after U.S. health regulators were unable to approve the drug maker's generic version of asthma medication Advair due to "minor deficiencies." SEE ALSO: Millennials are snapping up the 'Netflix of China' — and the stock has ...
Oracle – J.P. Morgan Securities downgraded the business software maker's stock to "neutral" from "overweight," saying ... but GE subsequently said …
CNBC · 10d
(WDTV)-Arms were out and flexing in Morgantown today at Mylan Park. The two-day event is packed with vendors and yes air born woodchips. Competitors hack their way through six rounds. They will be competing in the SpringBoard Chop, The Stihl Stock Saw ...
Local SourceWDTV · 22h
Stock Picks: Tailored Brands Inc (TLRD ... in the same period a year ago. Elsewhere, shares in Mylan NV (NASDAQ:MYL) lost over 3% to US$40.39 …
Having established its credentials in the global leagues with its Mylan tie up, this sharpshooter is my center ... On sunny days or torrential storms, these …
Overnight, rival Mylan said the US Food & Drug Administration will reject its generic version of Glaxo's blockbuster asthma drug Advair after finding "minor deficiencies". The company did not provide further details, leaving it unclear as to whether the ...
Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $38.74 to a high of $39.86. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $38.80 on volume of 3.5 million shares. Often times after large ...
SmarTrend · 9d